|
1
|
Abramson M and Huang CC: Localization of
collagenase in human middle ear cholesteatoma. Laryngoscope.
87:771–791. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yung M, Tono T, Olszewska E, Yamamoto Y,
Sudhoff H, Sakagami M, Mulder J, Kojima H, İncesulu A, Trabalzini
F, et al: EAONO/JOS joint consensus statements on the definitions,
classification and staging of middle ear cholesteatoma. J Int Adv
Otol. 13:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morita Y, Yamamoto Y, Oshima S, Takahashi
K and Takahashi S: Pediatric middle ear cholesteatoma: The
comparative study of congenital cholesteatoma and acquired
cholesteatoma. Eur Arch Otorhinolaryngol. 273:1155–1160. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xie S, Wang X, Ren J and Liu W: The role
of bone resorption in the etiopathogenesis of acquired middle ear
cholesteatoma. Eur Arch Otorhinolaryngol. 274:2071–2078. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Glikson E, Yousovich R, Mansour J, Wolf M,
Migirov L and Shapira Y: Transcanal endoscopic ear surgery for
middle ear cholesteatoma. Otol Neurotol. 38:e41–e45. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Locketz GD, Li PM, Fischbein NJ,
Holdsworth SJ and Blevins NH: Fusion of computed tomography and
PROPELLER diffusion-weighted magnetic resonance imaging for the
detection and localization of middle ear cholesteatoma. JAMA
Otolaryngol Head Neck Surg. 142:947–953. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lingam RK and Bassett P: A meta-analysis
on the diagnostic performance of non-echoplanar diffusion-weighted
imaging in detecting middle ear cholesteatoma: 10 years on. Otol
Neurotol. 38:521–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rogha M, Hashemi SM, Mokhtarinejad F,
Eshaghian A and Dadgostar A: Comparison of preoperative temporal
bone CT with intraoperative findings in patients with
cholesteatoma. Iran J Otorhinolaryngol. 26:7–12. 2014.PubMed/NCBI
|
|
9
|
Robert S, Gicquel T, Victoni T, Valença S,
Barreto E, Bailly-Maître B, Boichot E and Lagente V: Involvement of
matrix metalloproteinases (MMPs) and inflammasome pathway in
molecular mechanisms of fibrosis. Biosci Rep. 36:362016. View Article : Google Scholar
|
|
10
|
Kim M, Park SC, Baek I and Chun J:
Large-scale evaluation of experimentally determined DNA G+C
contents with whole genome sequences of prokaryotes. Syst Appl
Microbiol. 38:79–83. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmidt-Arras D and Rose-John S: IL-6
pathway in the liver: From physiopathology to therapy. J Hepatol.
64:1403–1415. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rysz J, Banach M, Stolarek RA, Pasnik J,
Cialkowska-Rysz A, Koktysz R, Piechota M and Baj Z: Serum matrix
metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue
inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol.
20:444–452. 2007.PubMed/NCBI
|
|
13
|
Trinidade A, Page JC and Dornhoffer JL:
Therapeutic mastoidectomy in the management of noncholesteatomatous
chronic otitis media: Literature review and cost analysis.
Otolaryngol Head Neck Surg. 155:914–922. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tono T, Sakagami M, Kojima H, Yamamoto Y,
Matsuda K, Komori M, Hato N, Morita Y and Hashimoto S: Staging and
classification criteria for middle ear cholesteatoma proposed by
the Japan Otological Society. Auris Nasus Larynx. 44:135–140. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matsuda K, Tono T, Kojima H, Yamamoto Y,
Sakagami M, Mishiro Y, Hinohira Y and Okuno T: Practicality
analysis of the staging system proposed by the Japan Otological
Society for acquired middle ear cholesteatoma: A multicenter study
of 446 surgical cases in Japan. Auris Nasus Larynx. 45:45–50. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rutkowska J, Özgirgin N and Olszewska E:
Cholesteatoma definition and classification: A literature review. J
Int Adv Otol. 13:266–271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki H, Ikezaki S, Imazato K, Koizumi H,
Ohbuchi T, Hohchi N and Hashida K: Partial mastoid obliteration
combined with soft-wall reconstruction for middle ear
cholesteatoma. Ann Otol Rhinol Laryngol. 123:571–575. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blanco P, González F, Holguín J and Guerra
C: Surgical management of middle ear cholesteatoma and
reconstruction at the same time. Colomb Med (Cali). 45:127–131.
2014.PubMed/NCBI
|
|
19
|
Zhu Z, Hong Y, Wang Y, He G and Ye S: The
significance of keratinocyte in hyperproliferation of middle ear
cholesteatoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
30:139–143. 2016.(In Chinese). PubMed/NCBI
|
|
20
|
Akkari M, Gabrillargues J, Saroul N,
Pereira B, Russier M, Mom T and Gilain L: Contribution of magnetic
resonance imaging to the diagnosis of middle ear cholesteatoma:
Analysis of a series of 97 cases. Eur Ann Otorhinolaryngol Head
Neck Dis. 131:153–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suchozebrska-Jesionek D, Szymański M,
Kurzepa J, Gołabek W and Stryjecka-Zimmer M: Gelatinolytic activity
of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma. J
Otolaryngol Head Neck Surg. 37:628–632. 2008.PubMed/NCBI
|
|
22
|
Schmidt M, Grünsfelder P and Hoppe F:
Up-regulation of matrix metalloprotease-9 in middle ear
cholesteatoma - correlations with growth factor expression in vivo?
Eur Arch Otorhinolaryngol. 258:472–476. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu W, Xie Y and Wang P: Expression of
matrix metalloproteinasa-2,9 in cholesteatoma and middle ear
cancer. Zhonghua Er Bi Yan Hou Ke Za Zhi. 36:119–122. 2001.(In
Chinese). PubMed/NCBI
|
|
24
|
Banerjee AR, James R and Narula AA: Matrix
metalloproteinase-2 and matrix metalloproteinase-9 in cholesteatoma
and deep meatal skin. Clin Otolaryngol Allied Sci. 23:345–347.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuczkowski J, Sakowicz-Burkiewicz M,
Iżycka-Świeszewska E, Mikaszewski B and Pawełczyk T: Expression of
tumor necrosis factor-α, interleukin-1α, interleukin-6 and
interleukin-10 in chronic otitis media with bone osteolysis. ORL J
Otorhinolaryngol Relat Spec. 73:93–99. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kumari N, Dwarakanath BS, Das A and Bhatt
AN: Role of interleukin-6 in cancer progression and therapeutic
resistance. Tumour Biol. 37:11553–11572. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu W, Xie S, Chen X, Rao X, Ren H, Hu B,
Yin T, Xiang Y and Ren J: Activation of the IL-6/JAK/STAT3
signaling pathway in human middle ear cholesteatoma epithelium. Int
J Clin Exp Pathol. 7:709–715. 2014.PubMed/NCBI
|
